KALARIS THERAPEUTICS, INC. Increase (Decrease) in Income Taxes
KALARIS THERAPEUTICS, INC. (KLRS) reported Increase (Decrease) in Income Taxes of -$128.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxes · last filed 2025-03-07
- KALARIS THERAPEUTICS, INC. increase (decrease) in income taxes for the quarter ending 2023-12-31 was $0.00.
- KALARIS THERAPEUTICS, INC. increase (decrease) in income taxes for the quarter ending 2023-09-30 was -$127.00K.
- KALARIS THERAPEUTICS, INC. increase (decrease) in income taxes for the quarter ending 2023-06-30 was -$3.00K.
- KALARIS THERAPEUTICS, INC. increase (decrease) in income taxes for the quarter ending 2023-03-31 was $2.00K.
- KALARIS THERAPEUTICS, INC. increase (decrease) in income taxes for fiscal 2023 was -$128.00K.
- KALARIS THERAPEUTICS, INC. increase (decrease) in income taxes for fiscal 2022 was -$879.00K, a 187.29% decline from fiscal 2021.
- KALARIS THERAPEUTICS, INC. increase (decrease) in income taxes for fiscal 2021 was $1.01M.
| Period end | Increase (Decrease) in Income Taxes 3 month | Increase (Decrease) in Income Taxes 6 month | Increase (Decrease) in Income Taxes 9 month | Increase (Decrease) in Income Taxes 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$127.00K derived: sum of 2 quarters · filed 2025-03-07 | -$130.00K derived: sum of 3 quarters · filed 2025-03-07 | -$128.00K 10-K · filed 2025-03-07 |
| 2023-09-30 | -$127.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$130.00K derived: sum of 2 quarters · filed 2024-11-12 | -$128.00K 10-Q · filed 2024-11-12 | -$154.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$1.00K 10-Q · filed 2024-08-09 | -$27.00K derived: sum of 3 quarters · filed 2024-08-09 | -$27.00K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $2.00K 10-Q · filed 2024-05-13 | -$24.00K derived: sum of 2 quarters · filed 2024-05-13 | -$24.00K derived: sum of 3 quarters · filed 2024-05-13 | -$377.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$26.00K derived: sum of 2 quarters · filed 2024-03-15 | -$379.00K derived: sum of 3 quarters · filed 2024-03-15 | -$879.00K 10-K · filed 2024-03-15 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$353.00K derived: sum of 2 quarters · filed 2023-11-02 | -$853.00K 10-Q · filed 2023-11-02 | |
| 2022-06-30 | -$353.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$853.00K 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | -$500.00K 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | $1.01M 10-K · filed 2023-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |